-
Something wrong with this record ?
Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV
N. Narsia, P. Ramagiri, J. Ehrmann, Z. Kolar
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
28452381
DOI
10.5507/bp.2017.020
Knihovny.cz E-resources
- MeSH
- Astrocytoma genetics pathology MeSH
- Molecular Targeted Therapy trends MeSH
- Adult MeSH
- Glioblastoma genetics pathology MeSH
- Humans MeSH
- Brain pathology MeSH
- Brain Neoplasms genetics pathology MeSH
- Cell Proliferation MeSH
- Gene Expression Regulation, Neoplastic * MeSH
- Sequence Analysis, RNA MeSH
- Signal Transduction MeSH
- Gene Expression Profiling * MeSH
- Neoplasm Grading MeSH
- Transcriptome genetics MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Astrocytoma is the most prevalent form of primary brain cancer categorized into four histological grades by the World Health Organization. Investigation into individual grades of astrocytoma by previous studies has provided some insight into dysregulation of regulatory networks associated with increasing astrocytoma grades. However, further understanding of key mechanisms that distinguish different astrocytoma grades is required to facilitate targeted therapies. METHODS: In this study, we utilized a large cohort of publicly available RNA sequencing data from patients with diffuse astrocytoma (grade II), anaplastic astrocytoma (grade III), primary glioblastoma (grade IV), secondary glioblastoma (grade IV), recurrent glioblastoma (grade IV), and normal brain samples to identify genetic similarities and differences between these grades using bioinformatics applications. RESULTS: Our analysis revealed a distinct gene expression pattern between grade II astrocytoma and grade IV glioblastoma (GBM). We also identified genes that were exclusively expressed in each of the astrocytoma grades. Furthermore, we identified known and novel genes involved in key pathways in our study. Gene set enrichment analysis revealed a distinct expression pattern of transcriptional regulators in primary GBM. Further investigation into molecular processes showed that the genes involved in cell proliferation and invasion were shared across all subtypes of astrocytoma. Also, the number of genes involved in metastasis, regulation of cell proliferation, and apoptosis increased with tumor grade. CONCLUSIONS: We confirmed existing findings and shed light on some important genes and molecular processes that will improve our understanding of glioma biology.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18025568
- 003
- CZ-PrNML
- 005
- 20180810085205.0
- 007
- ta
- 008
- 180711s2017 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2017.020 $2 doi
- 035 __
- $a (PubMed)28452381
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Narsia, Nato $u Department of Clinical and Molecular Pathology and Laboratory of Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
- 245 10
- $a Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV / $c N. Narsia, P. Ramagiri, J. Ehrmann, Z. Kolar
- 520 9_
- $a BACKGROUND: Astrocytoma is the most prevalent form of primary brain cancer categorized into four histological grades by the World Health Organization. Investigation into individual grades of astrocytoma by previous studies has provided some insight into dysregulation of regulatory networks associated with increasing astrocytoma grades. However, further understanding of key mechanisms that distinguish different astrocytoma grades is required to facilitate targeted therapies. METHODS: In this study, we utilized a large cohort of publicly available RNA sequencing data from patients with diffuse astrocytoma (grade II), anaplastic astrocytoma (grade III), primary glioblastoma (grade IV), secondary glioblastoma (grade IV), recurrent glioblastoma (grade IV), and normal brain samples to identify genetic similarities and differences between these grades using bioinformatics applications. RESULTS: Our analysis revealed a distinct gene expression pattern between grade II astrocytoma and grade IV glioblastoma (GBM). We also identified genes that were exclusively expressed in each of the astrocytoma grades. Furthermore, we identified known and novel genes involved in key pathways in our study. Gene set enrichment analysis revealed a distinct expression pattern of transcriptional regulators in primary GBM. Further investigation into molecular processes showed that the genes involved in cell proliferation and invasion were shared across all subtypes of astrocytoma. Also, the number of genes involved in metastasis, regulation of cell proliferation, and apoptosis increased with tumor grade. CONCLUSIONS: We confirmed existing findings and shed light on some important genes and molecular processes that will improve our understanding of glioma biology.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a astrocytom $x genetika $x patologie $7 D001254
- 650 _2
- $a mozek $x patologie $7 D001921
- 650 _2
- $a nádory mozku $x genetika $x patologie $7 D001932
- 650 _2
- $a proliferace buněk $7 D049109
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a stanovení celkové genové exprese $7 D020869
- 650 12
- $a regulace genové exprese u nádorů $7 D015972
- 650 _2
- $a glioblastom $x genetika $x patologie $7 D005909
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a cílená molekulární terapie $x trendy $7 D058990
- 650 _2
- $a stupeň nádoru $7 D060787
- 650 _2
- $a sekvenční analýza RNA $7 D017423
- 650 _2
- $a signální transdukce $7 D015398
- 650 _2
- $a transkriptom $x genetika $7 D059467
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ramagiri, Pradeep $u Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom
- 700 1_
- $a Ehrmann, Jiří, $u Department of Clinical and Molecular Pathology and Laboratory of Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic $d 1940- $7 xx0000871
- 700 1_
- $a Kolář, Zdeněk, $u Department of Clinical and Molecular Pathology and Laboratory of Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic $d 1953- $7 jn20000710256
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 161, č. 3 (2017), s. 261-271
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28452381 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20180711 $b ABA008
- 991 __
- $a 20180723095911 $b ABA008
- 999 __
- $a ok $b bmc $g 1324902 $s 1022490
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 161 $c 3 $d 261-271 $e 20170426 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20180711